Pharm Exec1h
New Spravato Indication Offers Greater Flexibility and Personalization for Patients with Treatment-Resistant Depression
Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the ...
Pharm Exec4h
FDA Approves AstraZeneca, Daiichi Sankyo’s Enhertu for Unresectable or Metastatic Hormone Receptor-Positive, HER2-Low Breast Cancer
Approval of Enhertu marks the first HER2-directed therapy indicated for adults with unresectable or metastatic HR-positive, ...
Pharm Exec11h
CStone and SteinCares Partner to Market and Commercialize Cancer Medication in Latin America
CStone, the drug’s developer, previously announced similar deals with various pharmaceutical companies to expand sugemalimab ...
Pharm Exec11h
Health In Tech Announces New Partnerships to Use AI-Powered Platform to Launch New Self-Funded Health Plan
Health In Tech announced new partnerships that it says will allow it to introduce a new self-funded health plan. 1 The ...